Quantcast
Last updated on April 24, 2014 at 11:16 EDT

Latest Technion Stories

2014-04-08 16:23:33

Future applications could include treatment for disfigurement after radical cancer surgery HAIFA, Israel, April 8, 2014 /PRNewswire-USNewswire/ -- A breakthrough could speed recovery and limit disfigurement for patients who have suffered large soft tissue trauma - as occurs with serious injury or cancer surgery. By biomedically engineering a muscle flap that includes a patient's own blood vessels, the team created tissue that could be transferred to other parts of the body along...

2013-11-05 20:23:06

NEW YORK, Nov. 5, 2013 /PRNewswire-USNewswire/ -- The American Committee for the Weizmann Institute of Science announced today that Nancy and Stephen Grand of San Francisco have committed $50 million to advance the international study of personalized medicine. The funds will be used by the Weizmann Institute of Science in Rehovot, Israel, to operate the recently established Israel National Center for Personalized Medicine (INCPM). The Grand gift is the single largest contribution...

2013-10-01 16:28:04

Program Will Train Technologists and Entrepreneurs to Drive Digital Transformation of the Media Industry NEW YORK, Oct. 1, 2013 /PRNewswire/ -- Cornell NYC Tech was joined by New York City Mayor Michael Bloomberg and leading media companies today to launch the first degree program to be offered by the Joan & Irwin Jacobs Technion-Cornell Innovation Institute (JTCII) at Cornell Tech. The two-year masters degree in Connective Media is designed to train the...

2013-06-27 12:28:32

Sealantis Conveys Nature's Power to Prevent Dangerous Leakage of Bodily Fluids HAIFA, Israel, June 27, 2013 /PRNewswire/ -- Sealantis [http://www.sealantis.co.il ] Ltd., a private start-up from the Technion-Israel Institute of Technology, reports that an eighth patient was treated with Seal-V, its alga-mimetic vascular sealant, as part of the company's first clinical study. Seal-V is a protein-free sealant, designed to resolve current limitations and challenges in control of...

2013-05-28 21:38:10

Cells have a sophisticated system to control and dispose of defective, superfluous proteins and thus to prevent damage to the body. Dr. Katrin Bagola and Professor Thomas Sommer of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch as well as Professor Michael Glickman and Professor Aaron Ciechanover of Technion, the Technical University of Israel in Haifa, have now discovered a new function of an enzyme that is involved in this vital process. Using yeast cells as...

2013-04-10 12:31:56

NEW YORK, April 10, 2013 /PRNewswire-USNewswire/ -- Researchers at the Technion-Israel Institute of Technology have developed and successfully demonstrated a photonic Floquet topological insulator, a new device used to protect the transport of light through a unique, lattice of 'waveguides.' The advancement may play a key role in the photonics industry. A description is published in the current issue of NATURE (11 April 2013). The photonics industry is at the heart of modern computing and...

2013-02-28 08:22:04

The new collaborative international project, headed by Technion Professor Rachelle Alterman, aims to bridge the legal-institutional gap in Mediterranean coastline management HAIFA, Israel, February 28, 2013 /PRNewswire/ -- The European Union (EU) has awarded the international Mare Nostrum [http://marenostrumproject.eu ] consortium EUR4.3 million to explore new ways of preserving the Mediterranean Sea and its coastline. The three-year project is aimed at bridging the...

2013-01-22 08:36:26

TEL AVIV, Israel, January 22, 2013 /PRNewswire/ -- The Technion-Israel Institute of Technology, one of the world's top institutions of its kind, announced the October 2013 launch of the international 'Start-uP MBA' program (http://www.technionmba.com). The leading Israeli institution will offer a prestigious MBA degree which embodies Israeli entrepreneurship and innovation in the 'start-up nation.' Exemplifying the highest academic standards fused with real-world...

2012-11-12 08:28:38

YOKNEAM, Israel, Nov. 12, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced the death of Marshall D. Butler, member of the Company's Board of Directors since 2003. (Logo: http://photos.prnewswire.com/prnh/20120528/535447) Shimon Eckhouse, Ph.D., Founder and Chairman of the Board of Syneron Medical, said, "Syneron, its Board of Directors, executives and employees are greatly saddened by the passing of a great friend, long-time...

2012-10-03 02:28:29

YOKNEAM, Israel, Oct. 3, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, honored Dr. Shimon Eckhouse, its founder and the inventor of IPL (Intense Pulsed Light), at a gala dinner held during the EADV (European Academy of Dermatology and Venerology) congress in Prague. The event, which was attended by over 100 key opinion leaders and industry professionals, celebrated the 20(th) anniversary of the invention of IPL, a technology that...